Angela Walsh - 26 Feb 2024 Form 4 Insider Report for Virios Therapeutics, Inc. (DWTX)

Role
SVP OF FINANCE
Signature
/s/ Greg Duncan, Attorney-in-Fact
Issuer symbol
DWTX
Transactions as of
26 Feb 2024
Net transactions value
$0
Form type
4
Filing time
28 Feb 2024, 12:51:34 UTC
Previous filing
14 Dec 2022
Next filing
01 Jul 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIRI Stock Option (right to buy) Award $0 +63,618 $0.000000 63,618 26 Feb 2024 Common Stock 63,618 $0.3570 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest 100% on February 26, 2025, one year following the grant date.